Skip to main content
James Malter, MD, Pathology, Dallas, TX

JamesSamuelMalterMD

Pathology Dallas, TX

Blood Banking & Transfusion Medicine, Molecular Genetics, Transplantation Immunology, Clinical Pathology

Chairman, Department of Pathology, UTSW

Dr. Malter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Malter's full profile

Already have an account?

  • Office

    5323 Harry Hines Blvd.
    Dallas, TX 75390
    Phone+1 214-648-4020
    Fax+1 214-648-4067

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1983 - 1988
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1983

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2012 - 2026
  • WI State Medical License
    WI State Medical License 1991 - 2011
  • PA State Medical License
    PA State Medical License 1985 - 1994
  • LA State Medical License
    LA State Medical License 1988 - 1993
  • American Board of Pathology Clinical Pathology
  • American Board of Pathology Blood Banking/Transfusion Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1998

Publications & Presentations

PubMed

Press Mentions

  • Could Drugs Used After an Organ Transplant Protect Against Alzheimer's?
    Could Drugs Used After an Organ Transplant Protect Against Alzheimer's?March 22nd, 2018
  • Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects Nonsmokers
    Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects NonsmokersOctober 24th, 2017
  • UTSW Research Finding Could Lead to Targeted Therapies for Inflammatory Bowel Diseases
    UTSW Research Finding Could Lead to Targeted Therapies for Inflammatory Bowel DiseasesNovember 19th, 2015

Grant Support

  • PIN1 Regulation Of Prosurvival Signalling In EosinophilsNational Heart, Lung, And Blood Institute2011
  • Regulation Of Tgf-B1 Production And Signaling By Pin-1National Heart, Lung, And Blood Institute2008–2011
  • PIN1 Regulation Of Prosurvival Signalling In EosinophilsNational Heart, Lung, And Blood Institute2008–2011
  • PIN1 In Synaptic Plasticity And TranslationNational Institute On Drug Abuse2009–2010
  • Cellular And Molecular Neuroscience CoreEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2010
  • APP MRNA Dysregulation And Alzheimer'S DiseaseNational Institute On Aging1991–2006
  • Molecular Mechanisms That Regulate Eosinophil Cytokine ProductionNational Heart, Lung, And Blood Institute2002–2005
  • Rhinovirus Infection Of Bronchial Epithelium &Il-8 MRNANational Institute Of Allergy And Infectious Diseases2001–2002
  • Cloning Of Early Response Genes From The Nervous SystemNational Institute Of Mental Health1999–2001
  • Molecular Mechanisms Of GM-CSF Production By Human EosinophilsNational Heart, Lung, And Blood Institute1997–2001
  • APP MRNA Dysregulation And Alzheimers DiseaseNational Institute On Aging1997–2000
  • Regulation Of Hematopoietic Growth Factor ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1994
  • Small Instrumentation GrantNational Institute Of Diabetes And Digestive And Kidney Diseases1990
  • NCI Clinical Investigator AwardNational Cancer Institute1988–1990